How to Buy Bolt Biotherapeutics Stock
Bolt Biotherapeutics Inc
Bolt Biotherapeutics, Inc. , a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system.
Bolt Biotherapeutics stock last closed at $1.16, down 3.33% from the previous day, and has decreased 27.5% in one year. It has underperformed other stocks in the Biotechnology industry by 0.04 percentage points. Bolt Biotherapeutics stock is currently +38.1% from its 52-week low of $0.84, and -42.86% from its 52-week high of $2.03.
At the moment, there are 38.13M BOLT shares outstanding. The market capitalization of BOLT is $44.23M. In the last 24 hours, 13,256 BOLT shares were traded.
How to Buy Bolt Biotherapeutics Stock
Not sure how to invest in Bolt Biotherapeutics stock? Here's how.
- Choose where to buy Bolt Biotherapeutics stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Bolt Biotherapeutics stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Pick your method of payment and add your info.
- Evaluate Bolt Biotherapeutics stock: The Bolt Biotherapeutics ticker symbol is BOLT. Is Bolt Biotherapeutics stock a good investment? Should you buy shares of BOLT? How do BOLT's underlying business fundamentals look? Do top analysts think Bolt Biotherapeutics is a good buy? Why has BOLT's stock price moved recently? (Hint: Our stock research website can help you understand if BOLT is a good stock to buy).
- Make your BOLT buy order: Decide if you will purchase BOLT shares at the current market price or use a limit order to purchase BOLT stock at a given price.
- Monitor your investment in BOLT: Create a watchlist to keep tabs on your new investment in Bolt Biotherapeutics stock.
Step 1: Choose where to buy Bolt Biotherapeutics stock
You will need an online brokerage account to access the NASDAQ market and buy BOLT shares.
Our recommended brokerage: eToro
We believe that eToro is the best place to buy stocks. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Technology to Energy, New York to Shanghai — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected your brokerage, you need to fill out some personal details so you can buy BOLT today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create a new brokerage account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have opened your account on the best stock app for beginners, you can securely and quickly fund your account:
Watch the video below for more details transferring money into your new investment account.
Step 4: Evaluate Bolt Biotherapeutics stock
Once you have decided on the best place to buy Bolt Biotherapeutics stock, it's absolutely critical to analyze their stock before you invest, so you actually comprehend the risk as well as the opportunity.
Bolt Biotherapeutics shares quick numbers
BOLT Due Diligence Checks
WallStreetZen was built to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on BOLT's stock page.
Is BOLT stock properly valued?
You can use many financial metrics, analyses, models, and charts to gauge BOLT's true value.
Using relative valuations methods:
- BOLT could be undervalued based on its P/B ratio of 0.39x, relative to Biotechnology industry P/B ratio of 5.8x
You can access additional valuation analysis on BOLT's stock here.
A look at BOLT Cashflows and Balance Sheet
Passed Health Checks:
- Total BOLT debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the BOLT balance sheet.
- BOLT has cash burn of 69731000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the BOLT balance sheet.
Failed Health Checks:
- BOLT profit margin has gone up by 6.59 percentage points in the past year, but the company is still unprofitable.
- BOLT has a relatively high debt to equity ratio of 0.42.
- BOLT has $103.95M in cash and short term investments. This is not enough to cover its annual cash burn of $69.73M.
Do Wall Street analysts think it's a good time to buy Bolt Biotherapeutics stock
Out of 1 Wall Street analysts who monitor BOLT, the consensus analyst rating on Bolt Biotherapeutics is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Bolt Biotherapeutics stock forecast page.
BOLT Momentum
BOLT Performance Metrics
Last year, BOLT revenue was $7.88M. In the past 4 year, BOLT's revenue has gone up by 146.02% per year. This was faster than the Biotechnology industry average of 28.62%.
You can research BOLT's earnings and revenue performance here.
Latest Insiders Trades at BOLT
Over the past year, insiders at BOLT have sold more shares than they have bought.
William P. Quinn, Chief Financial Officer of BOLT, was the latest BOLT insider to buy. They bought $7,125.00 worth of BOLT shares on Dec 12, 2023.
Dig into more about who owns BOLT stock here.
Can I rely on BOLT as an income stream?
No, Bolt Biotherapeutics doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your BOLT buy order
There are two primary options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly fine for most investors. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount, use a limit order.
Hit the Open button and your broker will place the order.
If you require additional help with buying stocks on eToro, watch the how to video below:
Step 6: Monitor your investment in BOLT
Now that you own some shares in BOLT, you'll want to stay up-to-date on your new stock purchase.
Start a watchlist to keep track of your BOLT stock.
BOLT Feed
How to Buy Stock in Bolt Biotherapeutics
To summarize, here are the 6 steps you need to take to buy Bolt Biotherapeutics stock right now:
- Choose where to buy Bolt Biotherapeutics stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Evaluate Bolt Biotherapeutics stock
- Make your BOLT buy order
- Monitor your investment in BOLT
If you need a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Bolt Biotherapeutics, add BOLT to your watchlist by clicking the button below.
More Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.